Latest Breaking News On - Rafal goraczniak - Page 1 : comparemela.com

A Rutgers professor’s novel research into targeting and silencing defective, disease-causing RNA molecules has led to the launch of Ceptur Therapeutics, a sta

Rafal goraczniakMichaele zwickP peter ghoroghchianSamueli gundersonTatiana litvin vechnyakRutgers new brunswick school of artsRutgers universityRutgers office for researchRutgers school of artsCeptur therapeuticsRutgers new brunswickRutgers innovation venturesRutgers officeSinnovation venturesRutgers schoolNa rutgers university new brunswick research jersey tech transfer